Transfusion medicine during COVID‐19 outbreak in the hotspot of Spain

por Hernández‐Maraver, Dolores, Viejo, Aurora, Kerguelén, Ana Esther, Jiménez‐Yuste, Victor
Publicado en Transfusion (2020)

Consecutive radiosynovectomy procedures at 6-monthly intervals behave independently in haemophilic synovitis

por De la Corte-Rodriguez, Hortensia, Rodriguez-Merchan, E. Carlos, Jimenez-Yuste, Victor
Publicado 2013

Point-of-care Ultrasonography in Orthopedic Management of Hemophilia: Multiple Uses of an Effective Tool

por De la Corte-Rodriguez, Hortensia, Rodriguez-Merchan, E. Carlos, Jimenez-Yuste, Víctor
Publicado en HSS J (2018)

Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future

por Jiménez-Yuste, Victor, Auerswald, Günter, Benson, Gary, Lambert, Thierry, Morfini, Massimo, Remor, Eduardo, Šalek, Silva Zupančić
Publicado 2014

Intra‐articular injections in people with haemophilia in the COVID‐19 era

por De La Corte‐Rodriguez, Hortensia, Rodriguez‐Merchan, Emerito Carlos, Alvarez‐Roman, Maria Teresa, Jimenez‐Yuste, Víctor
Publicado en Haemophilia (2020)

Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity

por Fernández-Bello, Ihosvany, López-Longo, Francisco J, Arias-Salgado, Elena G, Jiménez-Yuste, Víctor, Butta, Nora V
Publicado 2013

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data

por Eichler, Hermann, Angchaisuksiri, Pantep, Kavakli, Kaan, Knoebl, Paul, Windyga, Jerzy, Jiménez‐Yuste, Victor, Harder Delff, Philip, Chowdary, Pratima
Publicado en Haemophilia (2018)

Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic model

por Tiede, Andreas, Karim, Faraizah Abdul, Jiménez-Yuste, Victor, Klamroth, Robert, Lejniece, Sandra, Suzuki, Takashi, Groth, Andreas, Santagostino, Elena
Publicado en Haematologica (2020)

Tailoring care to haemophilia patients’ needs: which specialty and when?

por Morfini, Massimo, Benson, Gary, Jiménez-Yuste, Victor, Ljung, Rolf, Mannucci, Pier Mannuccio, Pasta, Gianluigi, Remor, Eduardo, Šalek, Silva Zupančić
Publicado en Blood Transfus (2015)

Pain and pain management in haemophilia

por Auerswald, Günter, Dolan, Gerry, Duffy, Anne, Hermans, Cedric, Jiménez-Yuste, Victor, Ljung, Rolf, Morfini, Massimo, Lambert, Thierry, Šalek, Silva Zupančić
Publicado en Blood Coagul Fibrinolysis (2016)

Practical aspects of extended half-life products for the treatment of haemophilia

por Lambert, Thierry, Benson, Gary, Dolan, Gerry, Hermans, Cedric, Jiménez-Yuste, Victor, Ljung, Rolf, Morfini, Massimo, Zupančić-Šalek, Silva, Santagostino, Elena
Publicado en Ther Adv Hematol (2018)

Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A:...

por Oldenburg, Johannes, Hay, Charles R M, Jiménez-Yuste, Víctor, Peyvandi, Flora, Schved, Jean-François, Szamosi, Johan, Winding, Bent, Lethagen, Stefan
Publicado en BMJ Open (2019)

Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4...

por Yaish, Hassan, Matsushita, Tadashi, Belhani, Meriem, Jiménez‐Yuste, Víctor, Kavakli, Kaan, Korsholm, Lars, Matytsina, Irina, Philipp, Claire, Reichwald, Kirsten, Wu, Runhui
Publicado en Haemophilia (2019)

Thromboprophylaxis in a patient with COVID‐19 and severe hemophilia A on emicizumab prophylaxis

por Rivas‐Pollmar, María Isabel, Álvarez‐Román, María Teresa, Butta‐Coll, Nora V., Martín Salces, Mónica, García‐Barcenilla, Sara, Jiménez‐Yuste, Victor
Publicado en J Thromb Haemost (2020)

Switching treatments in haemophilia: is there a risk of inhibitor development?

por Santagostino, Elena, Auerswald, Günter, Benson, Gary, Dolan, Gerry, Jiménez-Yuste, Victor, Lambert, Thierry, Ljung, Rolf, Morfini, Massimo, Remor, Eduardo, Zupančić Šalek, Silva
Publicado en Eur J Haematol (2015)

Principles of care for acquired hemophilia

por Dolan, Gerry, Benson, Gary, Bowyer, Annette, Eichler, Hermann, Hermans, Cedric, Jiménez‐Yuste, Victor, Ljung, Rolf, Pollard, Debra, Santagostino, Elena, Šalek, Silva Zupančić
Publicado en Eur J Haematol (2021)

Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaenia

por Álvarez Román, Maria Teresa, Fernández Bello, Ihosvany, Arias-Salgado, Elena G, de Paz, Raquel, Jiménez Yuste, Victor, Martín Salces, Monica, Butta, Nora V
Publicado en Br J Clin Pharmacol (2014)

Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors

por Šalek, Silva Zupančić, Auerswald, Günter, Benson, Gary, Dolan, Gerry, Duffy, Anne, Hermans, Cedric, Jiménez-Yuste, Victor, Ljung, Rolf, Morfini, Massimo, Santagostino, Elena, Lambert, Thierry
Publicado en Blood Transfus (2017)

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

por Ljung, Rolf, Auerswald, Guenter, Benson, Gary, Dolan, Gerry, Duffy, Anne, Hermans, Cedric, Jiménez‐Yuste, Victor, Lambert, Thierry, Morfini, Massimo, Zupančić‐Šalek, Silva, Santagostino, Elena
Publicado en Eur J Haematol (2018)

Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A

por Chowdary, Pratima, Carcao, Manuel, Holme, Pål A., Jiménez‐Yuste, Victor, Lentz, Steven R., Møss, Judi, Poulsen, Lone H., Shen, Chunduo, Tosetto, Alberto, Wheeler, Allison, Santagostino, Elena
Publicado en Res Pract Thromb Haemost (2019)